Bringing evidence to complementary and alternative medicine in children with cancer: Focus on nutrition-related therapies

Pediatric Blood and Cancer

Volumn 50, Issue 2 SUPPL., 2008, Pages 490-493

  Kelly, Kara M ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Alternative; Complementary; Dietary supplements; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; FOLINIC ACID; GLUTAMINE; HOMEOPATHIC AGENT; IMMUNOCAL; PROBIOTIC AGENT; PROTEIN; RETINOL; TRAUMEEL S; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALTERNATIVE MEDICINE; CACHEXIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILDHOOD CANCER; CLINICAL PRACTICE; CLINICAL TRIAL; COLOSTRUM; DIARRHEA; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HUMAN; MUCOSA INFLAMMATION; PRIORITY JOURNAL; REVIEW; STOMATITIS;

ANTIOXIDANTS; CHILD; COMPLEMENTARY THERAPIES; HUMANS; NEOPLASMS; NUTRITION THERAPY;

EID: 37549004406     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21402     Document Type: Review

References (22)

1. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: A systematic review. Cancer 1998;83:777-782.
2. Kelly KM. Complementary and alternative medicines for use in supportive care in pediatric cancer. Support Care Cancer 2007;15: 457-460.
3. Straus SE, Chesney MA. In defense of NCCAM. Science 2006; 313:303-304.
4. Vickers A. Botanical medicines for the treatment of cancer: Rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 2002;20:1069-1079.
5. Kelly KM, Jacobson JS, Kennedy DD. et al. Use of unconventional therapies by children with cancer at an urban medical center. J Pediatr Hematol Oncol 2000;22:412-416.
6. Ball SD, Kertesz D, Moyer-Mileur LJ. Dietary supplement use is prevalent among children with a chronic illness. J Am Diet Assoc 2005;105:78-84.
7. Post-White J, Hawks R, O'Mara A, et al. Future directions of CAM research in pediatric oncology. J Pediatr Oncol Nurs 2006;23:265-268.
8. Kennedy DD, Tucker KL, Ladas ED, et al. Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. Am J Clin Nutr 2004;79:1029-1036.
9. Kennedy DD, Ladas EJ, Rheingold SR, et al. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer 2005;44:378-385.
10. Oberbaum M, Yaniv I, Ben-Gal Y, et al. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer 2001;92:684-690.
11. Aquino VM, Harvey AR, Garvin JH, et al. A double-blind, randomized, placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: A pediatric blood and marrow transplant consortium study. Bone Marrow Transplant 2005;36:611-616.
12. Anderson PM, Ramsay NK, Shu XO. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant 1998;22:339-344.
13. Thornley I, Lehmann LE, Sung L, et al. A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2004;10:635-644.
14. Micke P, Beeh KM, Buhl R. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr 2002;41:12-18.
15. Grey V, Mohammed SR, Smountas AA, et al. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros 2003;2:195-198.
16. Kelly GS. Bovine colostrums: A review of clinical uses. Altern Med Rev 2003;8:378-394.
17. Inoue M, Okamura T, Sawada A, et al. Colostrum and severe gut GVHD. Bone Marrow Transplant 1998;22:402-403.
18. Tollemar J, Gross N, Dolgiras N, et al. Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients. Bone Marrow Transplant 1999;23:283-290.
19. Benchimol EI, Mack DR. Probiotics in relapsing and chronic diarrhea. J Pediatr Hematol Oncol 2004;26:515-517.
20. Ledoux D, Labombardi VJ, Karter D. Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin's disease. Int J STD AIDS 2006;17:280-282.
21. Buchanan DR, White JD, O'Mara AM, et al. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: Lessons from the National Cancer Institute Community Clinical Oncology Program experience. J Clin Oncol 2005;23:6682-6689.
22. Institute of Medicine at the National Academy of Sciences. Report on use of complementary and alternative medical therapies. Washington, D.C.: National Academy of Science Press; 2005.